Latest Insider Transactions at Natera, Inc. (NTRA)
This section provides a real-time view of insider transactions for Natera, Inc. (NTRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Natera, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Natera, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 21
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
602
-0.84%
|
$83,678
$139.29 P/Share
|
|
Jul 21
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,622
-0.92%
|
$225,458
$139.29 P/Share
|
|
Jul 21
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
339
-0.22%
|
$47,121
$139.29 P/Share
|
|
Jul 21
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
291
-0.23%
|
$40,449
$139.29 P/Share
|
|
Jul 21
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
93
-0.04%
|
$12,927
$139.29 P/Share
|
|
Jul 21
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
464
-0.23%
|
$64,496
$139.29 P/Share
|
|
Jul 20
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+2.07%
|
-
|
|
Jul 20
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.88%
|
-
|
|
Jul 20
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.08%
|
-
|
|
Jul 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.42%
|
-
|
|
Jul 16
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-1.23%
|
$457,430
$149.96 P/Share
|
|
Jul 02
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-1.35%
|
$480,000
$160.18 P/Share
|
|
Jul 01
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,299
-18.94%
|
$717,933
$167.31 P/Share
|
|
Jul 01
2025
|
Gail Boxer Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
4,299
+25.72%
|
$103,176
$24.42 P/Share
|
|
Jul 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.57%
|
$498,000
$166.23 P/Share
|
|
Jul 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,156
-0.41%
|
$355,740
$165.87 P/Share
|
|
Jul 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
3,187
-1.79%
|
$532,229
$167.19 P/Share
|
|
Jun 27
2025
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
2,143
+10.56%
|
-
|
|
Jun 27
2025
|
Monica Bertagnolli |
BUY
Grant, award, or other acquisition
|
Direct |
2,143
+29.92%
|
-
|
|
Jun 27
2025
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
2,414
+14.77%
|
-
|
|
Jun 27
2025
|
Gail Boxer Marcus |
BUY
Grant, award, or other acquisition
|
Direct |
2,414
+12.34%
|
-
|
|
Jun 27
2025
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
2,414
+1.72%
|
-
|
|
Jun 27
2025
|
Brinkley Ruth Williams |
BUY
Grant, award, or other acquisition
|
Direct |
2,143
+29.56%
|
-
|
|
Jun 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,908
-2.34%
|
$1,694,268
$171.07 P/Share
|
|
Jun 18
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-4.47%
|
$1,700,000
$170.18 P/Share
|
|
Jun 18
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-1.22%
|
$512,690
$167.29 P/Share
|
|
Jun 16
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-0.98%
|
$489,000
$163.98 P/Share
|
|
Jun 13
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
5,000
-14.29%
|
$825,000
$165.85 P/Share
|
|
Jun 10
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,000
-22.28%
|
$656,000
$164.68 P/Share
|
|
Jun 02
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,111
-1.11%
|
$959,427
$157.14 P/Share
|
|
Jun 02
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.55%
|
$471,000
$157.75 P/Share
|
|
May 28
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-22.22%
|
$1,610,000
$161.0 P/Share
|
|
May 27
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
1,438
-0.93%
|
$224,328
$156.85 P/Share
|
|
May 27
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,649
-1.27%
|
$257,244
$156.85 P/Share
|
|
May 20
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-18.18%
|
$1,530,000
$153.9 P/Share
|
|
May 16
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
19,000
-13.79%
|
$2,888,000
$152.85 P/Share
|
|
May 15
2025
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Indirect |
10,000
-11.9%
|
$1,500,000
$150.2 P/Share
|
|
May 12
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-1.08%
|
$474,000
$158.24 P/Share
|
|
May 09
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.17%
|
$488,130
$159.52 P/Share
|
|
May 01
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,000
-4.72%
|
$596,000
$149.99 P/Share
|
|
May 01
2025
|
Gail Boxer Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+22.59%
|
$96,000
$24.42 P/Share
|
|
May 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.54%
|
$450,000
$150.4 P/Share
|
|
May 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,980
-0.92%
|
$1,047,000
$150.37 P/Share
|
|
Apr 29
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,045
-1.05%
|
$468,930
$154.26 P/Share
|
|
Apr 28
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,018
-2.67%
|
$306,736
$152.18 P/Share
|
|
Apr 28
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
6,203
-3.13%
|
$942,856
$152.18 P/Share
|
|
Apr 28
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
1,709
-1.09%
|
$259,768
$152.18 P/Share
|
|
Apr 28
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Bona fide gift
|
Direct |
75
-0.05%
|
-
|
|
Apr 28
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
2,206
-1.56%
|
$335,312
$152.18 P/Share
|
|
Apr 28
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,993
-0.88%
|
$302,936
$152.18 P/Share
|